Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogensy and cytokine production by essential fatty acids

Immunology

Volumn 92, Issue 2, 1997, Pages 166-172

  Purasiri, P ^a,b   Mckechnie, A ^a   Heys, S D ^a   Eremin, O ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Samitivej Hospital Sukhumvit   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; CYTOKINE; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; GAMMA INTERFERON; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 1; INTERLEUKIN 2; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN K 562; CELLULAR IMMUNITY; CONTROLLED STUDY; DAUDI CELL; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; LYMPHOKINE ACTIVATED KILLER CELL; MALE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; POLYCLONAL ACTIVATION; PRIORITY JOURNAL;

EID: 0030826266     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.d01-2308.x     Document Type: Article

References (46)

1. HANNA N. (1985) The role of natural killer cells in the control of tumour growth and metastases. Biochim Biophys Acta 780, 213.
2. TRINCHIERI G. (1984) Perussia B. Biology of disease. Human natural killer cells: biologic and pathologic aspects. Lab Invest 50, 489.
3. BROOKS C.G. (1986) NK cell cloning technology and characteristics of NK cell clones. In: Immunobiology of Natural Killer Cells (ed. E. Lotzova & R. B. Herberman), Vol. II, p. 179.
4. REYNOLDS C.W. & WARD J.M. (1986) Tissue and organ distribution of NK cells In: Immunobiology of Natural Killer Cells (ed. E. Lotzova & R. B. Herberman), Vol. I, p. 63.
5. MAZUMDAR A. & ROSENBERG S.A. (1984) Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin-2. J Exp Med 159, 495.
6. ROSENGERG S.A. & LOTZE M.T. (1986) Cancer immunotherapy using interleukin-2 and interleukin-2 activated lymphocytes. Annu Rev Immunol 4, 681.
7. ROSENBERG S.A., LOTZE M.T., MUUL L.M, et al. (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. N Engl J Med 316, 889.
8. HEYS S.D., FRANKS C.R. & EREMIN O. (1993) Interleukin 2 therapy: current role in surgical oncological practice. Br J Surg 80, 155.
9. ERICKSON K.L., ADAM D.A. & MCNEILL C.J. (1983) Dietary lipid modulation of immune responsiveness. Lipids 18, 468.
10. HORROBIN D.F. (1983) The regulation of prostaglandins biosynthesis by manipulations of essential fatty acid metabolism. Rev Pure Appl Pharmac Sci 4, 339.
11. JOHNSTON D.V. & MARSHALL L.A. (1984) Dietary fat, prostaglandins and the immune response. Progress in FooD And Nutrition Science 8, 3.
12. BEGIN M.E., ELLS G., DAS U.N. & HORROBIN D.F. (1986) Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. JNCI 77, 1053.
13. MIZEL S.B. (1989) The interleukins. FASEB J 3, 2379.
14. POULAM M.P. & COLLINS M.K.L. (1992) Cytokine modulation of cell growth and role in tumour therapy. Eur J Cancer 28, 298.
15. KENNEDY R.L. & JONES T.H. (1991) Cytokines in endocrinology: their roles in health and in disease. J Endocrin 129, 167.
16. WU S., BOYER C.M., WHITAKER R.S. et al. (1993) Tumour necrosis factor-α as an autocrine and paracrine growth factor for ovarian cancer: monocrine induction of tumour cell proliferation and tumour necrosis factor-α expression. Cancer Res 53, 1939.
17. VAN MEIR E., SAWAMURA Y., DISERENS A.-C., HAMOU M.-F. & DE TRIBOLET N. (1990) Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res 50, 6683.
18. DINARELLO C.A. (1989) Biology of interleukin 1. FASEB J 2, 108.
19. GEARING A.J. & THORPE R. (1988) The international standard for human interleukin-2 calibration by international collaborative study. J Immunol Methods 114, 3.
20. CEROTTINI J.C. & BRUNNER K.T. (1974) Cell mediated cytotoxicity. allograft rejection and tumour immunity. Adv Immunol 18, 67.
21. ORTALDO J.R., BONNARD G.D. & HERBERMAN R.B. (1977) Cytotoxic reactivity of human lymphocytes cultured in vitro. J Immunol 119, 1351.
22. SPECTOR A.A., MATHUR S.N., KADUCE T.L. & HYMAN B.T. (1981) Lipid nutrition and metabolism of cultured mammalian cells. Prog Lipid Res 19, 155.
23. ROSENTHAL M.D. (1987) Fatty acid metabolism of isolated mammalian cells. Prog Lipid Res 26, 87.
24. ANEL A., NAVAL J., GONZALEZ B., URIEL J. & PINEIRO A. (1990) Fatty acid metabolism in human lymphocytes. II. Activation of fatty acid desaturase-elongase system during blastic transformation. Biochim Biophys Acta 1044, 332.
25. MEADE C.J. & MERTIN J. (1978) Fatty acids and immunity. Adv Lipid Res 16, 127.
26. GOLDYNE M.E. & STOBO J.D. (1981) Immunoregulatory role of prostaglandins and related lipids. Crit Rev Immun 2, 189.
27. HWANG D. (1989) Essential fatty acids and the immune response. FASEB J 3, 2052.
28. ERICKSON K.L. (1986) Dietary fat modulation of immune response. In J Immunopharmac 8, 529.
29. 4. J Immunol 131, 551.
30. RAMSTEDT U., SERHAN C.N., LUNDBERG U., WIGZELL H. & SAMUELSSON B. (1984) Inhibition of human natural killer cell activity by (14R, 15S)-14, 15-dihydroxy-5Z, 8Z, 10E-icosatetraenoic acid. Proc Natl Acad Sci USA 81, 6914.
31. MEYDANI S.N., ENDRES S., WOOD M.M. et al. (1991) Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. Nutr Immunol 121, 547.
32. CALDER P.C. & NEWSHOLME E.A. (1992) Polyunsaturated fatty acids suppress human peripheral blood lymphocyte proliferation and interleukin-2 production. Clin Sci 82, 695.
33. ENDRES S., GHORBANI R., KELLEY V.E. et al. (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumour necrosis factor by mononuclear cells. N Engl J Med 320, 265.
34. LOTZE MT. (1992) Interleukin 2. In: Human Cytokines Handbook for Basic and Clinical Research ( eds B. B. Aggarval & J. H. Gutterman), p. 81. Blackwell Scientific Publication, Boston.
35. ULLBERG M., JONDAL M., LANEFFLT F. & FREDHOLM B.B. (1983) Inhibition of human NK cell cytotoxicity by induction of cyclic AMP depends on impaired target cell recognition. Scand J Immunol 17, 365.
36. KUNKEL S.L., CHENSUE S.W. & PHAN S.W. (1986) Prostaglandins as endogenous mediators of interleukin 1 production. J Immunol 136, 186.
37. 5 is formed in human neutrophils after dietary supplementation with eicosapentaenoic acid. Proc Natl Acad Sci USA 82, 1540.
38. LEE T.H., HOOVER R.L., WILLIAMS J.D. et al. (1985) Effect of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 312, 1217.
39. ROLA-PLESZCZYNSKI M. & LEMAIRE I. (1985) Leukotrienes augment interleukin 1 production by human monocytes. J Immunol 135, 3958.
40. ROLA-PLESZCZYNSKI M., GAGNON L. & CHAVAELLAZ P.-A. (1988) Immune regulation by leukotriene B4. Am NY Acad Sci 524, 218.
41. BILLINGHAM M.E.J. (1987) Cytokines as inflammatory mediators. Br Med Bull 43, 350.
42. DINARELLO C.A., BISHAI I., ROSENWASSER L.J. & COCEANI F. (1984) The influence of lipoxygenase inhibitors on the in vitro production human leukocytic pyrogen and lymphocyte activating factor (interleukin 1). Int J Immunopharmacol 6, 43.
43. KUNKEL S.L. & CHENSUE S.W. (1985) Arachidonic acid metabolites regulate interleukin 1 production. Biochim Biophys Res Common 128, 892.
44. ZURIER R.B. (1993) Fatty acids, inflammation and the immune response. Prost Leuk EFA 48, 57.
45. SANTOLI D. & ZURIER R.B. (1989) Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-dependent mechanism. J Immunol 143, 1303.
46. MEYDANI S.N., ENDRES S., WOODS M.M. et al. (1991) Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: Comparison between young and older women. J Nutr 121, 547.